These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31444600)

  • 21. Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Liu JH; Soper D; Lukes A; Gee P; Kimble T; Kroll R; Mallick M; Chan A; Gillard P; Harrington A; Sniukiene V; Shulman LP
    Obstet Gynecol; 2018 Nov; 132(5):1241-1251. PubMed ID: 30303900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
    Koga K; Fukui M; Fujisawa M; Suzukamo Y
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study.
    Bongers M; Brölmann H; Gupta J; Garza-Leal JG; Toub D
    Gynecol Surg; 2015; 12(1):61-70. PubMed ID: 25774122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids.
    Wallace K; Stewart EA; Wise LA; Nicholson WK; Parry JP; Zhang S; Laughlin-Tommaso S; Jacoby V; Anchan RM; Diamond MP; Venable S; Shiflett A; Wegienka GR; Maxwell GL; Wojdyla D; Myers ER; Marsh E
    J Womens Health (Larchmt); 2022 Mar; 31(3):415-424. PubMed ID: 34101502
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.
    Venturella R; Lukes AS; Wu R; McLean R; Rakov VG; Al-Hendy A
    Int J Gynaecol Obstet; 2024 May; 165(2):431-441. PubMed ID: 38576220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of uterine fibroid embolization on lower urinary tract symptoms.
    Shveiky D; Iglesia CB; Antosh DD; Kudish BI; Peterson J; Huang CC; Spies JB
    Int Urogynecol J; 2013 Aug; 24(8):1341-5. PubMed ID: 23247276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids.
    Jacoby VL; Kohi MP; Poder L; Jacoby A; Lager J; Schembri M; Rieke V; Grady D; Vittinghoff E; Coakley FV
    Fertil Steril; 2016 Mar; 105(3):773-780. PubMed ID: 26658133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies.
    Haberland C; Filonenko A; Seitz C; Börner M; Gerlinger C; Doll H; Wessiepe D
    J Patient Rep Outcomes; 2020 Nov; 4(1):97. PubMed ID: 33185783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of transcervical resection of submucous fibroids on menstrual blood loss: A prospective cohort study.
    Keizer AL; Jacobs BL; Thurkow AL; de Lange ME; Radder CM; van Kesteren PJM; Hanstede MMF; Huirne JAF; Hehenkamp WJK
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():128-135. PubMed ID: 35640441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
    Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
    J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency Ablation for the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis by the AAGL Practice Committee.
    Chen I; Berman JM; Balk EM; Saldanha IJ; Kowalczewski E; Yi J; Zanotti S; Al Hilli M; Kho KA
    J Minim Invasive Gynecol; 2024 Sep; ():. PubMed ID: 39277104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.
    Christoffel L; Römer T; Schiermeier S
    Med Devices (Auckl); 2021; 14():77-84. PubMed ID: 33688276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine Fibroid Symptom - Quality of Life questionnaire translation and validation into Brazilian Portuguese.
    Silva RO; Gomes MT; Castro RA; Bonduki CE; Girão MJ
    Rev Bras Ginecol Obstet; 2016 Oct; 38(10):518-523. PubMed ID: 27832674
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
    Hervé F; Katty A; Isabelle Q; Céline S
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in pregnancy with uterine fibroid: a cross-sectional study in China.
    Ming WK; Wu H; Wu Y; Chen H; Meng T; Shen Y; Wang Z; Huang X; Sun W; Chow TS; Wang Y; Ding W; Chen H; Li Z; Wang Z
    Health Qual Life Outcomes; 2019 May; 17(1):89. PubMed ID: 31126289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.
    Roshdy E; Rajaratnam V; Maitra S; Sabry M; Allah AS; Al-Hendy A
    Int J Womens Health; 2013; 5():477-86. PubMed ID: 23950663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the Bleeding and Pelvic Discomfort Scale for Use in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
    Hudgens S; Gauthier M; Hunsche E; Kang J; Li Y; Scippa K; As-Sanie S
    Value Health; 2022 Dec; 25(12):1986-1994. PubMed ID: 35863945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric quantitative magnetic resonance imaging of uterine fibroids for prediction of growth rate-a pilot study.
    Medved M; Harmath CB; Siblini H; Giurcanu M; Kulkarni K; Hellman KM; Madueke-Laveaux OS
    Quant Imaging Med Surg; 2024 Jul; 14(7):4362-4375. PubMed ID: 39022288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials.
    Simon JA; Stewart EA; Jewell S; Li M; Snabes MC
    F S Rep; 2024 Sep; 5(3):285-295. PubMed ID: 39381651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.